Michael W. Dunne M.D.
Net Worth

Last updated:

What is Michael W. Dunne M.D. net worth?

The estimated net worth of Dr. Michael W. Dunne M.D. is at least $4,029,588 as of 22 Dec 2023. He owns shares worth $97,828 as insider and has received compensation worth at least $3,931,760 in Iterum Therapeutics plc.

What is the salary of Michael W. Dunne M.D.?

Dr. Michael W. Dunne M.D. salary is $561,680 per year as Strategic Advisor & Director in Iterum Therapeutics plc.

How old is Michael W. Dunne M.D.?

Dr. Michael W. Dunne M.D. is 65 years old, born in 1960.

What stocks does Michael W. Dunne M.D. currently own?

As insider, Dr. Michael W. Dunne M.D. owns shares in one company:

Company Title Shares Price per share Total value
Iterum Therapeutics plc (ITRM) Strategic Advisor & Director 113,754 $0.86 $97,828

What does Iterum Therapeutics plc do?

Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing and commercializing anti-infectives in Ireland, Bermuda, and the United States. It is developing sulopenem, a novel anti-infective compound with oral and IV formulations that is in Phase III clinical trials for the treatment of uncomplicated urinary tract infections, complicated urinary tract infections, and complicated intra-abdominal infections. The company was incorporated in 2015 and is headquartered in Dublin, Ireland.

ITRM logo
ITRM
Iterum Therapeutics plc
$0.86

Michael W. Dunne M.D. insider trading

Iterum Therapeutics plc

Dr. Michael W. Dunne M.D. has made only one insider trade between 2018-2023, according to the Form 4 filled with the SEC. He purchased 25,000 units of ITRM stock worth $35,000 on 22 Dec 2023.

As of 22 Dec 2023 he still owns at least 113,754 units of ITRM stock.

Transaction Date Security Shares Price per share Total value Source
Purchase
Ordinary Shares 25,000 $1.4 $35,000
Purchase
Ordinary Shares 10,000 $1.84 $18,440
Purchase
Ordinary Shares 20,000 $2.04 $40,700
Option
Restricted Share Units 3,487 N/A N/A
Option
Ordinary Shares 3,487 N/A N/A
Option
Restricted Share Units 1,779 N/A N/A
Option
Ordinary Shares 1,779 N/A N/A
Option
Ordinary Shares 15,853 N/A N/A
Option
Restricted Share Units 15,853 N/A N/A
Option
Restricted Share Units 1,299 N/A N/A
Option
Ordinary Shares 1,299 N/A N/A
Option
Ordinary Shares 1,299 N/A N/A
Option
Ordinary Shares 761 N/A N/A
Option
Restricted Share Units 761 N/A N/A
Purchase
Ordinary Shares 10,000 $2.22 $22,200
Option
Restricted Share Units 36,798 N/A N/A
Option
Ordinary Shares 36,798 N/A N/A
Option
Restricted Share Units 10,494 N/A N/A
Option
Ordinary Shares 10,494 N/A N/A
Sale
Ordinary Shares 33,143 N/A N/A
Purchase
Ordinary Shares 61,540 N/A N/A
Purchase
Warrants (right to buy) 46,155 $0.65 $30,001
Purchase
Ordinary Shares 500 $10 $5,000
Purchase
Ordinary Shares 500 N/A N/A
Purchase
Ordinary Shares 500 $10 $5,000
Purchase
Ordinary Shares 2,000 $13 $26,000

Iterum Therapeutics key executives

Iterum Therapeutics plc executives and other stock owners filed with the SEC: